Hyperkalemia: Clinical Trials

5 trials for Hyperkalemia, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

5 unknown. 5 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 45Unknown 5

Follow Hyperkalemia: new trials by email Literature Review of Hyperkalemia trials Research Report on Hyperkalemia

Trials (filtered) newest first · largest first

All 5 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Sodium Zirconium Cyclosilicate to Allow Liberal Fruit and Vegetable Intake for Patients With CKD Stage 3b and 4
Sodium zirconium cyclosilicate - Hyperkalemia, Diet Modification
Phase 4UnknownLeiden University Medical Center162024-04-292025-03-06
The Effect of Potassium Lowering Drugs on Cardiac Electrical Stability in Hemodialysis Patients (ART Study)
sodium zirconium cyclic silicate - Potassium Imbalance, Cardiac Arrhythmia
Phase 4UnknownPeking University First Hospital612022-02-142024-02-05
Levalbuterol Compared to Albuterol Regarding Cardiac Side Effects and Potassium Lowering Effects.
Levalbuterol, Albuterol - Hyperkalemia
Phase 4UnknownUniversity of Aleppo302021-11-042021-12-30
The Effect of Sodium Zirconium Cyclosilicate on Albuminuria in Patients With Type 2 Diabetes and Hyperkalemia
LOKELMA 5 GM Powder for Oral Suspension, Placebos - Type 2 Diabetes Mellitus With Kidney Complications
Phase 4UnknownSteno Diabetes Center Copenhagen202019-10-012019-10-16
Aldosterone in Diabetic Nephropathy
Spironolactone, Placebo - Diabetic Nephropathy
Phase 4UnknownUniversidad de los Andes, Chile1602009-03-012009-03-27

Narrower conditions

Renal Insufficiency, Chronic (2)  ·  Albuminuria (1)  ·  Arrhythmias, Cardiac (1)  ·  Diabetic Nephropathies (1)

Broader conditions

Metabolic Diseases (5)  ·  Nutritional and Metabolic Diseases (5)  ·  Water-Electrolyte Imbalance (5)  ·  Female Urogenital Diseases (3)  ·  Female Urogenital Diseases and Pregnancy Complications (3)  ·  Kidney Diseases (3)  ·  Male Urogenital Diseases (3)  ·  Pathological Conditions, Signs and Symptoms (3)  ·  Urogenital Diseases (3)  ·  Urologic Diseases (3)  ·  Chronic Disease (2)  ·  Disease Attributes (2)  ·  Pathologic Processes (2)  ·  Renal Insufficiency (2)  ·  Cardiovascular Diseases (1)

Interventions

Albuterol (1)  ·  Levalbuterol (1)  ·  Renal Dialysis (1)  ·  Spironolactone (1)  ·  Suspensions (1)  ·  sodium zirconium cyclosilicate (1)

Sponsors

Leiden University Medical Center (1)  ·  Peking University First Hospital (1)  ·  Steno Diabetes Center Copenhagen (1)  ·  Universidad de los Andes, Chile (1)  ·  University of Aleppo (1)

Countries

Chile (1)  ·  China (1)  ·  Denmark (1)  ·  Netherlands (1)  ·  Syria (1)

Top investigators

Baraa Shebli, M.D. (1)  ·  Mahmoud Malhis, MRCP (1)

Results publications

PMID 33107592, PMID 41437987

NIH funding

2019 (1), 2023 (1)